Global Clinical Diagnostics Automation Market
Global Clinical Diagnostics Automation Market

Clinical Diagnostics Automation Comprehensive Study by Type (Modular Automation, Total Lab Automation), Application (Clinical Diagnostics, Drug Discovery, Proteomics Solutions, Others) Players and Region - Global Market Outlook to 2024

Clinical Diagnostics Automation Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 224 Pages 196 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Clinical Diagnostics Automation Market Scope
Clinical diagnosis automation offers precise operations in the field of medical diagnosis. There are various advantages associated with clinical diagnosis automation such as affordable treatment, safer solutions, fast service with high accuracy, longer-lasting equipment, less risk of lawsuits and many others. Advancements in newborn screening & breast cancer advances and technological developments in ebola diagnostics due to the growing emergence of an ebola outbreak have been supplementing the overall growth of the market. However, lack of adoption of clinical diagnostic automation among small and medium-sized laboratories and higher initial investments, as well as expensive sensors, might stagnate the demand for clinical diagnostic automation.

The market study is being classified by Type (Modular Automation and Total Lab Automation), by Application (Clinical Diagnostics, Drug Discovery, Proteomics Solutions and Others) and major geographies with country level break-up.

The Players having a strong hold in the market are Abaxis, Abbott Diagnostics, Beckman Coulter, Becton, Dickinson, and bioMrieux SA. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Clinical Diagnostics Automation market throughout the predicted period.

Abaxis, Inc. (United States), Abbott Diagnostics, Inc. (United States), Beckman Coulter, Inc. (United States), Becton, Dickinson, and Company (United States), bioMrieux SA (France), Bio-Rad Laboratories, Inc. (United States), Diagnostica Stago S.A.S. (France), Eppendorf AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), HORIBA ABX S.A.S. (France), Hudson Robotics, Inc. (United States) and Ortho Clinical Diagnostics, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are PerkinElmer Inc. (United States), QIAGEN NV (Netherlands), Siemens Healthineers (United States), Sysmex America, Inc. (United States), Tecan Group Ltd. (Switzerland), The ELITechGroup SAS (France) and Thermo Fisher Scientific, Inc. (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Clinical Diagnostics Automation market by Type, Application and Region.

On the basis of geography, the market of Clinical Diagnostics Automation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.

Market Leaders and their expansionary development strategies

On May 6, 2019, Abbott has launched a new, smarter heart monitor for better arrhythmia detection positive news for people at risk for irregular heartbeats. Now with CE Mark in Europe and U.S. Food and Drug Administration (FDA) clearance, the next-generation Confirm Rx insertable cardiac monitor (ICM), a paperclip-sized implantable device, combines smartphone connectivity and continuous, remote monitoring to track unpredictable heart rhythm problems for a fast and accurate diagnosis.


Market Trend
  • Upsurging Advancements in Newborn Screening & Breast Cancer Advances
  • Upsurging Technological Developments in Ebola Diagnostics due to the growing emergence of an Ebola outbreak

Market Drivers
  • Upsurging Demand for Accurate Clinical Diagnostics
  • Growing Geriatric Population across the Globe

Opportunities
  • Emerging Markets Provide an Array of Opportunities to Clinical Diagnostics System Providers
  • Wide Scope and Increasing Adoption in Microbiology

Restraints
  • Lack of Adoption of Clinical Diagnostic Automation among Small and Medium-Sized Laboratories
  • Higher Initial Investments, as well as Expensive Sensors, might Stagnate the Demand

Challenges
  • Complexities in Technological Installment and Existing System Integrations
  • Skilled Workforce required in Developing Highly Automated Systems


Key Target Audience
Clinical Diagnostics Automation Service Providers, Clinical Diagnostics Service Providers, Upstream and Downstream Buyers, Government Agencies, Research and Development Institutes and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Modular Automation
  • Total Lab Automation
By Application
  • Clinical Diagnostics
  • Drug Discovery
  • Proteomics Solutions
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Upsurging Demand for Accurate Clinical Diagnostics
      • 3.2.2. Growing Geriatric Population across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Complexities in Technological Installment and Existing System Integrations
      • 3.3.2. Skilled Workforce required in Developing Highly Automated Systems
    • 3.4. Market Trends
      • 3.4.1. Upsurging Advancements in Newborn Screening & Breast Cancer Advances
      • 3.4.2. Upsurging Technological Developments in Ebola Diagnostics due to the growing emergence of an Ebola outbreak
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Clinical Diagnostics Automation, by Type, Application and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Clinical Diagnostics Automation (Value)
      • 5.2.1. Global Clinical Diagnostics Automation by: Type (Value)
        • 5.2.1.1. Modular Automation
        • 5.2.1.2. Total Lab Automation
      • 5.2.2. Global Clinical Diagnostics Automation by: Application (Value)
        • 5.2.2.1. Clinical Diagnostics
        • 5.2.2.2. Drug Discovery
        • 5.2.2.3. Proteomics Solutions
        • 5.2.2.4. Others
      • 5.2.3. Global Clinical Diagnostics Automation Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Clinical Diagnostics Automation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abaxis, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Diagnostics, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Beckman Coulter, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson, and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioMrieux SA (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Diagnostica Stago S.A.S. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eppendorf AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. HORIBA ABX S.A.S. (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Hudson Robotics, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Ortho Clinical Diagnostics, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Clinical Diagnostics Automation Sale, by Type, Application and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Clinical Diagnostics Automation (Value)
      • 7.2.1. Global Clinical Diagnostics Automation by: Type (Value)
        • 7.2.1.1. Modular Automation
        • 7.2.1.2. Total Lab Automation
      • 7.2.2. Global Clinical Diagnostics Automation by: Application (Value)
        • 7.2.2.1. Clinical Diagnostics
        • 7.2.2.2. Drug Discovery
        • 7.2.2.3. Proteomics Solutions
        • 7.2.2.4. Others
      • 7.2.3. Global Clinical Diagnostics Automation Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Clinical Diagnostics Automation: by Type(USD Billion)
  • Table 2. Clinical Diagnostics Automation Modular Automation , by Region USD Billion (2013-2018)
  • Table 3. Clinical Diagnostics Automation Total Lab Automation , by Region USD Billion (2013-2018)
  • Table 4. Clinical Diagnostics Automation: by Application(USD Billion)
  • Table 5. Clinical Diagnostics Automation Clinical Diagnostics , by Region USD Billion (2013-2018)
  • Table 6. Clinical Diagnostics Automation Drug Discovery , by Region USD Billion (2013-2018)
  • Table 7. Clinical Diagnostics Automation Proteomics Solutions , by Region USD Billion (2013-2018)
  • Table 8. Clinical Diagnostics Automation Others , by Region USD Billion (2013-2018)
  • Table 9. South America Clinical Diagnostics Automation, by Country USD Billion (2013-2018)
  • Table 10. South America Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 11. South America Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 12. Brazil Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 13. Brazil Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 14. Argentina Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 15. Argentina Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 16. Rest of South America Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 17. Rest of South America Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 18. Asia Pacific Clinical Diagnostics Automation, by Country USD Billion (2013-2018)
  • Table 19. Asia Pacific Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 20. Asia Pacific Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 21. China Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 22. China Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 23. Japan Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 24. Japan Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 25. India Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 26. India Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 27. South Korea Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 28. South Korea Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 29. Taiwan Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 30. Taiwan Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 31. Australia Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 32. Australia Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 33. Rest of Asia-Pacific Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 34. Rest of Asia-Pacific Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 35. Europe Clinical Diagnostics Automation, by Country USD Billion (2013-2018)
  • Table 36. Europe Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 37. Europe Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 38. Germany Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 39. Germany Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 40. France Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 41. France Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 42. Italy Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 43. Italy Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 44. United Kingdom Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 45. United Kingdom Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 46. Netherlands Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 47. Netherlands Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 48. Rest of Europe Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 49. Rest of Europe Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 50. MEA Clinical Diagnostics Automation, by Country USD Billion (2013-2018)
  • Table 51. MEA Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 52. MEA Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 53. Middle East Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 54. Middle East Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 55. Africa Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 56. Africa Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 57. North America Clinical Diagnostics Automation, by Country USD Billion (2013-2018)
  • Table 58. North America Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 59. North America Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 60. United States Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 61. United States Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 62. Canada Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 63. Canada Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 64. Mexico Clinical Diagnostics Automation, by Type USD Billion (2013-2018)
  • Table 65. Mexico Clinical Diagnostics Automation, by Application USD Billion (2013-2018)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Clinical Diagnostics Automation: by Type(USD Billion)
  • Table 79. Clinical Diagnostics Automation Modular Automation , by Region USD Billion (2019-2024)
  • Table 80. Clinical Diagnostics Automation Total Lab Automation , by Region USD Billion (2019-2024)
  • Table 81. Clinical Diagnostics Automation: by Application(USD Billion)
  • Table 82. Clinical Diagnostics Automation Clinical Diagnostics , by Region USD Billion (2019-2024)
  • Table 83. Clinical Diagnostics Automation Drug Discovery , by Region USD Billion (2019-2024)
  • Table 84. Clinical Diagnostics Automation Proteomics Solutions , by Region USD Billion (2019-2024)
  • Table 85. Clinical Diagnostics Automation Others , by Region USD Billion (2019-2024)
  • Table 86. South America Clinical Diagnostics Automation, by Country USD Billion (2019-2024)
  • Table 87. South America Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 88. South America Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 89. Brazil Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 90. Brazil Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 91. Argentina Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 92. Argentina Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 93. Rest of South America Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 94. Rest of South America Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 95. Asia Pacific Clinical Diagnostics Automation, by Country USD Billion (2019-2024)
  • Table 96. Asia Pacific Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 97. Asia Pacific Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 98. China Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 99. China Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 100. Japan Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 101. Japan Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 102. India Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 103. India Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 104. South Korea Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 105. South Korea Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 106. Taiwan Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 107. Taiwan Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 108. Australia Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 109. Australia Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 110. Rest of Asia-Pacific Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 111. Rest of Asia-Pacific Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 112. Europe Clinical Diagnostics Automation, by Country USD Billion (2019-2024)
  • Table 113. Europe Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 114. Europe Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 115. Germany Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 116. Germany Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 117. France Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 118. France Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 119. Italy Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 120. Italy Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 121. United Kingdom Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 122. United Kingdom Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 123. Netherlands Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 124. Netherlands Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 125. Rest of Europe Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 126. Rest of Europe Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 127. MEA Clinical Diagnostics Automation, by Country USD Billion (2019-2024)
  • Table 128. MEA Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 129. MEA Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 130. Middle East Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 131. Middle East Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 132. Africa Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 133. Africa Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 134. North America Clinical Diagnostics Automation, by Country USD Billion (2019-2024)
  • Table 135. North America Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 136. North America Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 137. United States Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 138. United States Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 139. Canada Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 140. Canada Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 141. Mexico Clinical Diagnostics Automation, by Type USD Billion (2019-2024)
  • Table 142. Mexico Clinical Diagnostics Automation, by Application USD Billion (2019-2024)
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Clinical Diagnostics Automation: by Type USD Billion (2013-2018)
  • Figure 5. Global Clinical Diagnostics Automation: by Application USD Billion (2013-2018)
  • Figure 6. South America Clinical Diagnostics Automation Share (%), by Country
  • Figure 7. Asia Pacific Clinical Diagnostics Automation Share (%), by Country
  • Figure 8. Europe Clinical Diagnostics Automation Share (%), by Country
  • Figure 9. MEA Clinical Diagnostics Automation Share (%), by Country
  • Figure 10. North America Clinical Diagnostics Automation Share (%), by Country
  • Figure 11. Global Clinical Diagnostics Automation share by Players 2018 (%)
  • Figure 12. Global Clinical Diagnostics Automation share by Players (Top 3) 2018(%)
  • Figure 13. Global Clinical Diagnostics Automation share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Abaxis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Abaxis, Inc. (United States) Revenue: by Geography 2018
  • Figure 17. Abbott Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Diagnostics, Inc. (United States) Revenue: by Geography 2018
  • Figure 19. Beckman Coulter, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Beckman Coulter, Inc. (United States) Revenue: by Geography 2018
  • Figure 21. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 22. Becton, Dickinson, and Company (United States) Revenue: by Geography 2018
  • Figure 23. BioMrieux SA (France) Revenue, Net Income and Gross profit
  • Figure 24. BioMrieux SA (France) Revenue: by Geography 2018
  • Figure 25. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2018
  • Figure 27. Diagnostica Stago S.A.S. (France) Revenue, Net Income and Gross profit
  • Figure 28. Diagnostica Stago S.A.S. (France) Revenue: by Geography 2018
  • Figure 29. Eppendorf AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Eppendorf AG (Germany) Revenue: by Geography 2018
  • Figure 31. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2018
  • Figure 33. HORIBA ABX S.A.S. (France) Revenue, Net Income and Gross profit
  • Figure 34. HORIBA ABX S.A.S. (France) Revenue: by Geography 2018
  • Figure 35. Hudson Robotics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Hudson Robotics, Inc. (United States) Revenue: by Geography 2018
  • Figure 37. Ortho Clinical Diagnostics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Ortho Clinical Diagnostics, Inc. (United States) Revenue: by Geography 2018
  • Figure 39. Global Clinical Diagnostics Automation: by Type USD Billion (2019-2024)
  • Figure 40. Global Clinical Diagnostics Automation: by Application USD Billion (2019-2024)
  • Figure 41. South America Clinical Diagnostics Automation Share (%), by Country
  • Figure 42. Asia Pacific Clinical Diagnostics Automation Share (%), by Country
  • Figure 43. Europe Clinical Diagnostics Automation Share (%), by Country
  • Figure 44. MEA Clinical Diagnostics Automation Share (%), by Country
  • Figure 45. North America Clinical Diagnostics Automation Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abaxis, Inc. (United States)
  • Abbott Diagnostics, Inc. (United States)
  • Beckman Coulter, Inc. (United States)
  • Becton, Dickinson, and Company (United States)
  • bioMrieux SA (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • Diagnostica Stago S.A.S. (France)
  • Eppendorf AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • HORIBA ABX S.A.S. (France)
  • Hudson Robotics, Inc. (United States)
  • Ortho Clinical Diagnostics, Inc. (United States)
Additional players considered in the study are as follows:
PerkinElmer Inc. (United States) , QIAGEN NV (Netherlands) , Siemens Healthineers (United States) , Sysmex America, Inc. (United States) , Tecan Group Ltd. (Switzerland) , The ELITechGroup SAS (France) , Thermo Fisher Scientific, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation